Your browser doesn't support javascript.
loading
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling.
Lee, Seolah; Kim, Hyun Chul; Jang, Yoonhyuk; Lee, Han Sang; Ahn, Seon-Jae; Lee, Soon-Tae; Jung, Keun-Hwa; Park, Kyung-Il; Jung, Ki-Young; Oh, Jaeseong; Lee, SeungHwan; Yu, Kyung-Sang; Jang, In-Jin; Lee, Soyoung; Chu, Kon; Lee, Sang Kun.
Afiliação
  • Lee S; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Kim HC; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Jang Y; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.
  • Lee HS; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Ahn SJ; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Lee ST; Center for Hospital Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Jung KH; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Park KI; Center for Hospital Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Jung KY; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Oh J; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Lee S; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Yu KS; Division of Neurology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea.
  • Jang IJ; Laboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Chu K; Department of Pharmacology, Jeju National University College of Medicine, Jeju Special Self-Governing Province, Republic of Korea.
  • Lee SK; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
Ann Clin Transl Neurol ; 11(2): 424-435, 2024 02.
Article em En | MEDLINE | ID: mdl-38062636
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Frutose / Anticonvulsivantes Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Frutose / Anticonvulsivantes Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article